Cargando…

Effectiveness of very low doses of immunotherapy in advanced renal cell cancer.

Twenty-one nephrectomized patients with metastatic renal cell cancer were treated with recombinant interleukin 2 (rlL-2) and interferon alpha (rIFN alpha). rIL-2 was administered s.c. at a dose of 1 x 10(6) IU m(-2) every 12 h on days 1 and 2, followed by 0.5 x 10(6) IU twice daily on days 3-5; rIFN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buzio, C., De Palma, G., Passalacqua, R., Potenzoni, D., Ferrozzi, F., Cattabiani, M. A., Manenti, L., Borghetti, A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1997
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2227980/ https://www.ncbi.nlm.nih.gov/pubmed/9275034

Ejemplares similares

Rapamycin in preventive (very low) doses
por: Kondratov, Roman V., et al.
Publicado: (2014)

Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose
por: Demoly, Pascal, et al.
Publicado: (2015)

Biological effects of hadrons at very low doses
por: Baarli, Johan, et al.
Publicado: (1976)

Low-Dose Immunotherapy: Is It Just an Illusion?
por: Meriggi, Fausto, et al.
Publicado: (2023)

Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma
por: Tang, Tin-Yun, et al.
Publicado: (2021)

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
por: Rini, Brian I., et al.
Publicado: (2019)

Colostrum oropharyngeal immunotherapy for very low birth weight preterm infants: protocol of an intervention study
por: da Cruz Martins, Camilla, et al.
Publicado: (2020)

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
por: Lissoni, P., et al.
Publicado: (1993)

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma
por: Verra, N, et al.
Publicado: (2003)

The role of immunotherapy in advanced renal cell carcinoma
por: Mondlane, Ercília Rita, et al.
Publicado: (2021)

Very-Low-Dose Radiation and Clinical Molecular Nuclear Medicine
por: Tsai, Chi-Jung, et al.
Publicado: (2022)

The effect of very low dose pulsed magnetic waves on cochlea()
por: Tuhanioğlu, Birgül, et al.
Publicado: (2018)

DC-Based Immunotherapy Combined with Low-Dose Methotrexate Effective in the Treatment of Advanced CIA in Mice
por: Park, Jun-Eui, et al.
Publicado: (2015)

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
por: Gromeier, Matthias, et al.
Publicado: (2021)

Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields
por: Costa, F P, et al.
Publicado: (2011)

Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia
por: Spyridonidis, A, et al.
Publicado: (2011)

Low-dose irradiation for reversing immunotherapy resistance: how to translate?
por: Ochoa-de-Olza, Maria, et al.
Publicado: (2022)

Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia
por: Thompson, Andrew B., et al.
Publicado: (2014)

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
por: Xu, Ying, et al.
Publicado: (2015)

Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma.
por: Pession, A., et al.
Publicado: (1998)

A very long-acting IL-15: implications for the immunotherapy of cancer
por: Hangasky, John A, et al.
Publicado: (2022)

Supplemented Very Low Protein Diet (sVLPD) in Patients with Advanced Chronic Renal Failure: Clinical and Economic Benefits
por: Cecchi, Sofia, et al.
Publicado: (2023)

Temperatures very low and very high
por: Zemansky, Mark Waldo, 1900-
Publicado: (1964)

Temperatures very low and very high
por: Zemansky, Mark Waldo 1900-
Publicado: (1981)

Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
por: Menon, Hari, et al.
Publicado: (2019)

Update on combined immunotherapy for the treatment of advanced renal cell carcinoma
por: Gebrael, Georges, et al.
Publicado: (2023)

The effect of well-characterized, very low-dose x-ray radiation on fibroblasts
por: Truong, Katelyn, et al.
Publicado: (2018)

Effect of Very Low-Dose Hydrocortisone on Shock Reversal in Patients With Septic Shock
por: Sbertoli, Robert, et al.
Publicado: (2020)

Very low-dose radiation therapy for management of inflammatory myofibroblastic tumor of the lung
por: Najjar, Nimeh, et al.
Publicado: (2022)

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
por: Bi, Kevin, et al.
Publicado: (2021)

Feasibility, Safety, and Preliminary Efficacy of Very Low-Volume Interval Training in Advanced Cancer Patients
por: RELJIC, DEJAN, et al.
Publicado: (2022)

Recommendations for appropriate sublingual immunotherapy clinical trials
por: Passalacqua, Giovanni
Publicado: (2014)

A 3D Finite Element Model of the Reversible Critical Current Reduction Due to Transverse Load in Nb$_{3}$Sn Wires
por: Cattabiani, A, et al.
Publicado: (2020)

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma
por: Gilles, Rozemarie, et al.
Publicado: (2011)

Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy
por: Lewicky, Jordan D., et al.
Publicado: (2022)

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer
por: Eisen, T, et al.
Publicado: (2000)

Effects of Very Low Dose Fast Neutrons on Cell Membrane And Secondary Protein Structure in Rat Erythrocytes
por: Saeed, A., et al.
Publicado: (2015)

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
por: Herrera, Fernanda G., et al.
Publicado: (2022)

The treatment of advanced renal cell cancer with high-dose oral thalidomide
por: Stebbing, J, et al.
Publicado: (2001)

The Very Low-Dose Dexamethasone Suppression Test in the General Population: A Cross-Sectional Study
por: Direk, Nese, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6g3gr4n9gbeib7u46j20ee5365